Can Pharma Sustain Earnings As Tax Oversight Tightens?
This article was originally published in Scrip
Executive Summary
The deal between Pfizer Inc. and Allergan PLC having re-ignited the debate over the US tax regime and the competitive pressures on companies to side-step its powers, a new report from Credit Suisse's accounting and tax research team makes for interesting reading.